TITLE

Review: Drug-eluting stents are more effective than bare-metal stents for reducing acute MI at 6 to 12 months after implantation

PUB. DATE
July 2007
SOURCE
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study, conducted by R. Moreno and colleagues, which compares the effectiveness of drug-eluting stents (DESs) and bare-metal stents (BMSs) for reducing risk for acute myocardial infarction (MI) in patients undergoing stent implantation. They conducted randomized controlled trials that compared DESs with BMSs. They found that DESs are more effective than BMSs for reducing risk for acute MI at 6 to 12 months after implantation.
ACCESSION #
25913649

 

Related Articles

  • Review: Sirolimus-eluting stents do not differ from bare-metal stents for long-term survival in CAD.  // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p14 

    The article cites a study, conducted by A. Kastrati and colleagues, which compares sirolimus-eluting stents (SESs) with bare-metal stents (BMSs) for long-term survival in patients with coronary artery disease (CAD). They conducted randomized controlled trials to compare SESs with BMSs. They...

  • Review: Rescue percutaneous coronary intervention but not repeated fibrinolysis is effective for failed fibrinolysis in STEMI.  // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p11 

    The article cites a study, conducted by H.C. Wijeysundera and colleagues, which focuses on the benefits and risks of rescue percutaneous coronary intervention (PCI) or repeated fibrinolytic therapy compared with conservative management in patients with ST-segment elevation myocardial infarction...

  • Thrombus aspiration comes of age in primary PCI.  // Heart;Jun2008, Vol. 94 Issue 6, p819 

    The article presents a study on the application of Thrombus aspiration to patients during percutaneous coronary intervention (PCI). The Thrombus Aspiration during Percutaneous Coronary Intervention In Acute Myocardial Infarction (TAPAS) randomized trial was used in evaluating the patients....

  • SHORT CUTS.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/15/2010, Vol. 340 Issue 7755, p1058 

    This section presents an overview of research studies related to medicine published in other general journals. A randomised trial conducted in Sydney, New South Wales has found that growth hormones failed to work well for 96 volunteer athletes in terms of endurance, strength and power. A decline...

  • Mendelian Randomization. Thanassoulis, George; O'Donnell, Christopher J. // JAMA: Journal of the American Medical Association;6/10/2009, Vol. 301 Issue 22, p2386 

    The authors analyze a study which examined the causal role of lipoprotein(a) in myocardial infarction. They argue that the study offered insights using the mendelian randomization approach. They add that the study showed how mendelian randomization could be utilized to improve the evidence for...

  • Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease. Stone, Gregg W.; Midei, Mark; Newman, William; Sanz, Mark; Hermiller, James B.; Williams, Jerome; Farhat, Naim; Mahaffey, Kenneth W.; Cutlip, Donald E.; Fitzgerald, Peter J.; Sood, Poornima; Xiaolu Su; Lansky, Alexandra J. // JAMA: Journal of the American Medical Association;4/23/2008, Vol. 299 Issue 16, p1903 

    The article presents a study comparing the angiographic outcomes in coronary artery disease patients using everolimus-eluting verses those using paclitaxel-eluting stents. The objectives, design and setting of the controlled patient trial are defined. Research showed that the everolimus stent...

  • Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention. Ethgen, Morgane; Boutron, Isabelle; Gabriel^Steg, Philippe; Roy, Carine; Ravaud, Philippe // Trials;2009, Vol. 10, p1 

    Background: The aim of this study was to assess the reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention. Methods: The study design was a methodological systematic review of randomized controlled trials. The data sources were MEDLINE and the...

  • Two cases of very late bare-metal stent thrombosis and literature review. SIMSEK, Z.; KOZA, Y.; TAS, M. H.; LAZOGLU, Z.; IPEK, E. // European Review for Medical & Pharmacological Sciences;Jun2014 Supplement, Vol. 18, p1674 

    BACKGROUND: Bare metal stents (BMS) are commonly used in the treatment of coronary artery disease. Very late stent thrombosis (VLST) is a quite rare clinical entity. However, it is a serious complication that often results myocardial infarction or death. Since the stent endothelialization is...

  • Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock.  // JAMA: Journal of the American Medical Association;4/18/2007, Vol. 297 Issue 15, p1657 

    The article presents a randomized controlled trial that examined the effects of the nitric oxide synthase inhibitor tilarginine acetate in patients with myocardial infarction and refractory cardiogenic shock. All patients in the study had an open infarct artery. Outcomes measured in the study...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics